In a groundbreaking leap for biotechnology, GenEditBio has announced the successful dosing of the first patient in an investigator-initiated trial (IIT) of GEB-101, their revolutionary in vivo genome editing program for TGFBI corneal dystrophy. This marks the world’s first use of in vivo genome editing therapy for this particular condition, a move that stands as […]
Tag: therapy
CRISPR Therapeutics Develops Gene-Editing Therapies
In a quantum leap for the biotech industry, CRISPR Therapeutics is blazing a trail through the field of genetic medicine, rapidly advancing its pioneering CRISPR/Cas9 gene-editing platform to tackle diseases like hemoglobinopathies, cancer, diabetes, and more. Shares of CRSP rose by 3.9% on June 17, bolstered by recent developments and the promise of a new […]